www.corcept.com Open in urlscan Pro
35.193.101.241  Public Scan

Submitted URL: http://corcept.com/
Effective URL: https://www.corcept.com/
Submission: On March 13 via manual from SG — Scanned from SG

Form analysis 1 forms found in the DOM

GET https://www.corcept.com

<form role="search" method="get" class="search-form" action="https://www.corcept.com">
  <div><label for="s" class="search-form__label">Search</label><input placeholder="" type="text" value="" name="s" class="search-input" autocomplete="off"><button type="submit" class="search-button" value="Search">Search</button>
  </div>
</form>

Text Content

Skip to content

Main Menu
 * Contact Us
 * SearchSearch

 * AboutShow submenu
   * About Corcept
   * Executive Team
   * Board of Directors
   * Educational Grants
   * Contact Us
 * ProductShow submenu
   * Korlym® for Cushing Syndrome
   * Medical Information Request
 * Patients
 * Research & PipelineShow submenu
   * Cortisol Modulation
   * Cortisol Modulation Therapeutic Platform
   * Pipeline and Clinical Trials
   * Publications
   * Investigator-Initiated Studies
   * Compassionate Use
 * InvestorsShow submenu
   * Investors Overview
   * Press Releases
   * Events
   * Corporate Governance
   * Analyst Coverage
   * Stock Information
   * SEC Filings
 * CareersShow submenu
   * Working at Corcept
   * Benefits
   * Testimonials
   * Current Opportunities


PIONEERING THE DISCOVERY AND DEVELOPMENT OF CORTISOL MODULATORS

Developing cortisol modulators for a broad range of serious diseases, including
endocrine, metabolic, oncologic, and psychiatric disorders

Scroll Down


COMMITMENT TOSCIENCE

We lead the field in the research and development of selective glucocorticoid
receptor (GR) antagonists.


IMPACT OF EXCESS CORTISOL AND UNDERSTANDING GR ANTAGONISM

Learn More


RESEARCH & PIPELINE

Learn More


COMMITMENT TOPATIENTS

We are committed to developing novel medications for patients suffering from
diseases driven by cortisol dysregulation.

Learn More



COMMITMENT TOCULTURE

We foster a diverse and collaborative environment focused on developing novel
therapies that help treat people with serious unmet medical needs.

Learn More

 * 
 * Science
 * Patients
 * Culture

 * About
   * Executive Team
   * Board of Directors
   * Educational Grants
     * Contact Us
 * Product
   * Korlym for Cushing Syndrome
   * Medical Information Request
   * Patients
 * Research & Pipeline
   * Cortisol Modulation
   * Cortisol Modulation Therapeutic Platform
   * Pipeline and Clinical Trials
   * Publications
   * Investigator-Initiated Studies
   * Compassionate Use
 * Investors
   * Investors Overview
   * Press Releases
   * Events
   * Corporate Governance
   * Analyst Coverage
   * Stock Information
   * SEC Filings
 * Careers
   * Benefits
   * Testimonials
   * Current Opportunities

© 2023 Corcept
 * Privacy Notice
 * Terms of Use
 * Site Map

This website uses cookies to help us give you the best experience when you
visit. By continuing to use this website, you consent to the use of these
cookies. To find out more about how we use cookies and how you can manage them
go to our Cookie Notice.

Accept